Find the right Medicare plan for 2025 — compare coverage and costs in minutes.

Compare Medicare Plans →
Medicare News MedCity News

FDA Nod for Merck HIV Drug Brings Competition to a Gilead Sciences Antiretroviral

Merck’s HIV drug Idvynso could become a drug choice for patients who need to switch from Gilead Sciences’ Biktarvy for safety or tolerability reasons. The Merck combination drug pairs two molecules that bring different mechanisms of action to suppressing HIV. The post FDA Nod for Merck HIV Drug Brings Competition to a Gilead Sciences Antiretroviral appeared first on MedCity News .

Read full article →
Medicare News MedCity News

Wearable Noise Is Exploding — Trust Is the Filter

The challenge is determining whether wearable data is reliable enough to relieve the review burden, guide care, support reimbursement, or reassure a patient who is worried about their heart rhythm at two o’clock in the morning. The post Wearable Noise Is Exploding — Trust Is the Filter appeared first on MedCity News .

Read full article →